Literature DB >> 6211316

Pharmacological modification of immunoregulatory T lymphocytes. I. Effect of adenosine, H1 and H2 histamine agonists upon T lymphocyte regulation of B lymphocyte differentiation in vitro.

R E Birch, S H Polmar.   

Abstract

Human peripheral blood T lymphocytes were fractionated according to the lability of their sheep red blood cell (E) receptors to theophylline. Theophylline sensitive (Ts) cells function as suppressors of pokeweed mitogen induced B cell differentiation into plasma cells, while theophylline resistant (Tr) cells function as helper/inducer cells in this reaction. The Ts fraction is enriched for cells bearing receptors for the Fc portion of IgG (RFc gamma) while the Tr fraction is depleted of RFc gamma bearing cells. Brief exposure of Tr cells to adenosine or impromidine, an H2 histamine agonist, cause a rapid increase in the number of Tr cells bearing RFc gamma and the development of radioresistant suppressor cell activity. The RFc gamma induced on Tr cells by adenosine or impromidine are more stable in culture than the spontaneously occurring RFc gamma on Ts cells. Ts suppressor activity is radiosensitive and exposure of Ts cells to 2(2-pyridyl)ethylamine, an H1 histamine agonist, results in a marked decrease in RFc gamma on Ts cells as well as loss of Ts suppressor activity. These data indicate that RFc gamma expression and the immunoregulatory function of T lymphocyte subsets may be modified by drugs acting upon adenosine, H1 and H2 histamine receptors.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6211316      PMCID: PMC1536592     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

1.  Subclasses of T cells with different sensitivities to cytotoxic antibody in the presence of anesthetics.

Authors:  S K Lee; J Singh; R B Taylor
Journal:  Eur J Immunol       Date:  1975-04       Impact factor: 5.532

2.  Lymphocytes in the rabbit expressing receptors for the Fc portion of rabbit immunoglobulin.

Authors:  R E Birch; G M Bernier; M W Fanger
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

3.  Induction and separation of antigen-dependent T helper and T suppressor cells in man.

Authors:  A Shore; H Dosch; E W Gelfand
Journal:  Nature       Date:  1978-08-10       Impact factor: 49.962

Review 4.  Immunological circuits: cellular composition.

Authors:  H Cantor; R K Gershon
Journal:  Fed Proc       Date:  1979-06

5.  Cytochemical identification of monocytes and granulocytes.

Authors:  L T Yam; C Y Li; W H Crosby
Journal:  Am J Clin Pathol       Date:  1971-03       Impact factor: 2.493

6.  Enhancement by irradiated T cells of human plasma cell production: dissection of helper and suppressor functions in vitro.

Authors:  F P Siegal; M Siegal
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

7.  Theophylline modulation of E-rosette formation: an indicator of T-cell maturation.

Authors:  S Limatibul; A Shore; H M Dosch; E W Gelfand
Journal:  Clin Exp Immunol       Date:  1978-09       Impact factor: 4.330

8.  Modulation of cellular-immune responses in vivo and in vitro by histamine receptor-bearing lymphocytes.

Authors:  R E Rocklin
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

9.  Two functionally distinct subpopulations of human T cells that collaborate in the generation of cytotoxic cells responsible for cell-mediated lympholysis.

Authors:  R L Evans; H Lazarus; A C Penta; S F Schlossman
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

10.  Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG.

Authors:  L Moretta; S R Webb; C E Grossi; P M Lydyard; M D Cooper
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

View more
  9 in total

Review 1.  Pharmacological modification of immunoregulatory activity of lymphocytes: facts and potential.

Authors:  S H Polmar
Journal:  Surv Immunol Res       Date:  1984

2.  Diabetes-induced decrease of adenosine kinase expression impairs the proliferation potential of diabetic rat T lymphocytes.

Authors:  Monika Sakowicz-Burkiewicz; Katarzyna Kocbuch; Marzena Grden; Andrzej Szutowicz; Tadeusz Pawelczyk
Journal:  Immunology       Date:  2006-07       Impact factor: 7.397

3.  Characterization of suppressor T cells for antibody production by chicken spleen cells. II. Comparison of CT8+ cells from concanavalin A-injected normal and bursa cell-injected agammaglobulinaemic chickens.

Authors:  P Quere; B S Bhogal; G J Thorbecke
Journal:  Immunology       Date:  1990-12       Impact factor: 7.397

4.  In vivo effects of a single infusion of theophylline on human peripheral blood lymphocytes.

Authors:  R Pardi; M R Zocchi; E Ferrero; G F Ciboddo; L Inverardi; C Rugarli
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

5.  Abnormal adenosine-induced immunosuppression and cAMP metabolism in T lymphocytes of patients with systemic lupus erythematosus.

Authors:  R Mandler; R E Birch; S H Polmar; G M Kammer; S A Rudolph
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

6.  Pharmacological modification of immunoregulatory T lymphocytes . II. Modulation of T lymphocyte cell surface characteristics.

Authors:  R E Birch; A K Rosenthal; S H Polmar
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330

7.  Impaired T cell capping and receptor regeneration in active systemic lupus erythematosus. Evidence for a disorder intrinsic to the T lymphocyte.

Authors:  G M Kammer
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

8.  Changes in bronchial anaphylactic reactivity induced in guinea-pigs by long-term treatment with histamine H2-agents.

Authors:  P Andersson; H Bergstrand
Journal:  Br J Pharmacol       Date:  1984-05       Impact factor: 8.739

9.  T lymphocytes as a target of histamine action.

Authors:  Tomasz Kmiecik; Aneta Otocka-Kmiecik; Małgorzata Górska-Ciebiada; Maciej Ciebiada
Journal:  Arch Med Sci       Date:  2012-02-29       Impact factor: 3.318

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.